| __timestamp | Amphastar Pharmaceuticals, Inc. | AstraZeneca PLC |
|---|---|---|
| Wednesday, January 1, 2014 | 28427000 | 5579000000 |
| Thursday, January 1, 2015 | 37065000 | 5997000000 |
| Friday, January 1, 2016 | 41199000 | 5890000000 |
| Sunday, January 1, 2017 | 43415000 | 5757000000 |
| Monday, January 1, 2018 | 57564000 | 5932000000 |
| Tuesday, January 1, 2019 | 68853000 | 5958000000 |
| Wednesday, January 1, 2020 | 67229000 | 5991000000 |
| Friday, January 1, 2021 | 60932000 | 9736000000 |
| Saturday, January 1, 2022 | 74771000 | 9762000000 |
| Sunday, January 1, 2023 | 73741000 | 10935000000 |
| Monday, January 1, 2024 | 13583000000 |
Igniting the spark of knowledge
In the ever-evolving pharmaceutical industry, research and development (R&D) is the lifeblood of innovation. Over the past decade, AstraZeneca PLC and Amphastar Pharmaceuticals, Inc. have demonstrated contrasting R&D investment strategies. AstraZeneca, a global leader, has consistently allocated substantial resources, with R&D expenses peaking at approximately $10.9 billion in 2023, marking a 96% increase from 2014. This commitment underscores AstraZeneca's focus on pioneering treatments and maintaining its competitive edge.
Conversely, Amphastar Pharmaceuticals, a smaller player, has shown a steady yet modest increase in R&D spending, reaching around $73.7 million in 2023, a 160% rise since 2014. This growth reflects Amphastar's strategic focus on niche markets and incremental innovation. The disparity in R&D investment between these two companies highlights the diverse approaches within the pharmaceutical sector, where both giants and niche players carve their paths to success.
Novo Nordisk A/S or AstraZeneca PLC: Who Invests More in Innovation?
R&D Insights: How Novo Nordisk A/S and Amphastar Pharmaceuticals, Inc. Allocate Funds
Johnson & Johnson vs AstraZeneca PLC: Strategic Focus on R&D Spending
R&D Insights: How AstraZeneca PLC and argenx SE Allocate Funds
Research and Development Investment: AstraZeneca PLC vs Teva Pharmaceutical Industries Limited
Who Prioritizes Innovation? R&D Spending Compared for AstraZeneca PLC and Biogen Inc.
Analyzing R&D Budgets: AstraZeneca PLC vs BeiGene, Ltd.
Research and Development: Comparing Key Metrics for AstraZeneca PLC and Ascendis Pharma A/S
Research and Development Investment: Vertex Pharmaceuticals Incorporated vs Amphastar Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Jazz Pharmaceuticals plc and Amphastar Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Apellis Pharmaceuticals, Inc. and Amphastar Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Amicus Therapeutics, Inc. and Amphastar Pharmaceuticals, Inc.